Latest stories on ATNM
Actinium Pharmaceuticals’ ATNM-400 shows anti-tumor activity in prostate cancer
The Fly64 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. (ATNM) Presents at European Association of Nuclear Medicine Annual Congress 2026 - Slideshow
Seeking Alpha52 · neutralproduct/pr
Actinium Pharmaceuticals Announces Inducement Grants to New Employees
PR Newswire52 · neutralgeneral
Actinium Pharmaceuticals Announces Inducement Grants to New Employees
StockTitan52 · neutralproduct/pr
Actinium Pharmaceuticals to present ATNM-400 data at EANM
The Fly56 · neutralproduct/pr
Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
PR Newswire56 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. (ATNM) files 8-K
SEC 8-K50 · neutralgeneral
Actinium Pharmaceuticals names former CorMedix executive as CFO
Seeking Alpha53 · neutralgeneral
Actinium Pharmaceuticals appoints Matt David as CFO
The Fly52 · neutralgeneral
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
PR Newswire58 · neutralgeneral
Targeted Alpha Therapy Market Size to Hit USD 11.52 Billion by 2035 from USD 1.25 Billion in 2025 at CAGR of 24.9% - SNS Insider
GlobeNewswire63 · neutralgeneral
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire55 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
StockTitan56 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. (ATNM) files 8-K
SEC 8-K50 · neutralgeneral